SUMMARY: A review of type III effectors (T3 effectors) from strains of Xanthomonas reveals a growing list of candidate and known effectors based on functional assays and sequence and structural similarity searches of genomic data. We propose that the effectors and suspected effectors should be distributed into 39 so‐called Xop groups reflecting sequence similarity. Some groups have structural motifs for putative enzymatic functions, and recent studies have provided considerable insight into the interaction with host factors in their function as mediators of virulence and elicitors of resistance for a few specific T3 effectors. Many groups are related to T3 effectors of plant and animal pathogenic bacteria, and several groups appear to have been exploited primarily by Xanthomonas species based on available data. At the same time, a relatively large number of candidate effectors remain to be examined in more detail with regard to their function within host cells.
13 January 2014 in Proceedings of the National Academy of Sciences
Significance: Citrus bacterial canker, which is caused by several species in the genus Xanthomonas , is a severe disease with worldwide distribution affecting all the commercially important citrus species and cultivars. The mechanisms of canker development, involving erumpent pustule formation and bacterial growth, are not known. Our findings suggest that virulence determinants in several pathogens activate a single host disease susceptibility (S) gene that has a critical contribution to bacterial growth and host pustule development. The S gene represents an excellent candidate for control measures for the citrus bacterial canker.
8 September 2007 in Annual Review of Phytopathology
The use of phages for disease control is a fast expanding area of plant protection with great potential to replace the chemical control measures now prevalent. Phages can be used effectively as part of integrated disease management strategies. The relative ease of preparing phage treatments and low cost of production of these agents make them good candidates for widespread use in developing countries as well. However, the efficacy of phages, as is true of many biological control agents, depends greatly on prevailing environmental factors as well as on susceptibility of the target organism. Great care is necessary during development, production and application of phage treatments. In addition, constant monitoring for the emergence of resistant bacterial strains is essential. Phage-based disease control management is a dynamic process with a need for continuous adjustment of the phage preparation in order to effectively fight potentially adapting pathogenic bacteria.